ArticleFrontiers in immunology2026

Short term ex vivo graft conditioning with venetoclax, fluticasone propionate, and IL-2 reduces graft versus host disease in mouse allogeneic hematopoietic cell transplantation.

L Angel Ayala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.